For people who are seriously ill and not eligible for a clinical trial, the main pathway to access investigational medicines, Janssen accepts requests for our investigational medicines from their treating physicians. Below are the number of patients to whom Janssen has provided pre-approval access (PAA) annually since 2015:

For more information about PAA at Janssen, please click here.